Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection
Top Cited Papers
- 15 March 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (6) , 2180-2186
- https://doi.org/10.1182/blood-2003-07-2375
Abstract
Hypergammaglobulinemia and defective humoral immunity are hallmarks of HIV-1 infection. Naive B cells have been recently suggested as the major source of hypergammaglobulinemia in chronic viral infections. We recently reported that HIV-1–infected patients carry low levels of memory B cells. Here we studied whether defects in the naive and memory B cells in HIV-1–infected patients translated into hypergammaglobulinemia and defective humoral immunity against specific antigens. Naive B cells from HIV-1–infected patients exhibited abnormal expression of the activation/differentiation markers CD70 and leukocyte-associated Ig-like receptor (LAIR-1). Activated naive B cells from patients showed a significant increase in the intracellular immunoglobulin G (IgG) content ex vivo and this activated phenotype correlated to hypergammaglobulinemia and to the ability of naive B cells from patients to secrete IgG in vitro. We analyzed the levels of antibodies to tetanus toxoid, measles, and HIV-1 in relation to memory B cells and observed a significant reduction of antigen-specific antibodies in patients with low-memory B lymphocytes. Nevertheless, hypergammaglobulinemia and levels of polyspecific self-reactive antibodies were comparable in patients with normal and low memory B cells. We conclude that reduction of memory B lymphocytes in HIV-1 infection correlates with defective humoral immunity and that hyperactivated naive B cells may represent the source of abnormal IgG production in HIV-1 infection. Our results may be relevant to the design of HIV-1 therapeutical vaccines and to the clinical management of HIV-1–infected patients.Keywords
This publication has 56 references indexed in Scilit:
- Maintenance of Serological Memory by Polyclonal Activation of Human Memory B CellsScience, 2002
- Potent Antiretroviral Therapy Initiates Normalization of Hypergammaglobulinemia and a Decline in HIV Type 1-Specific Antibody ResponsesAIDS Research and Human Retroviruses, 2001
- Polyspecific Self‐Reactive Antibodies in Individuals Infected with Human Immunodeficiency Virus Facilitate T Cell Deletion and Inhibit Costimulatory Accessory Cell FunctionThe Journal of Infectious Diseases, 1999
- HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral TherapyThe Journal of Experimental Medicine, 1998
- Low Levels of IgG Antibodies Against Pneumocystis carinii Among HIV-infected PatientsScandinavian Journal of Infectious Diseases, 1998
- Functional B Cell Abnormalities in HIV Type 1 Infection: Role of CD40L and CD70AIDS Research and Human Retroviruses, 1997
- Human antibodies from phage libraries: neutralizing activity against human immunodeficiency virus type 1 equally improved after expression as Fab and IgG in mammalian cellsEuropean Journal of Immunology, 1996
- Increased Risk of Early Measles in Infants of Human Immunodeficiency Virus Type 1-Seropositive MothersThe Journal of Infectious Diseases, 1992
- Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patientsClinical and Experimental Immunology, 1991
- Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983